Picture of IDEXX Laboratories logo

IDXX — IDEXX Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

IDEXX Labs rises on quarterly results beat

** Shares of animal diagnostics maker IDEXX Laboratories
 IDXX.O  rise 8.5% to $458 premarket
    ** IDXX posts Q4 rev. of $954.3 mln, above analysts' est. of
 $935 mln, according to data compiled by LSEG, driven by strong
demand for its veterinary diagnostic services despite persistent
weakness in visits to the vet clinic
    ** IDXX posts Q4 adj. EPS of $2.62/shr, above analysts' est.
of $2.40/shr - LSEG
    ** IDXX forecasts 2025 rev. between $4.06 bln and $4.17 bln,
the midpoint of which is slightly below analysts' estimates of
$4.14 bln
    ** IDXX forecasts 2025 EPS to be between $11.74 and $12.24
per share vs. analysts' est. of $11.92 per share
    ** IDXXn fell ~25% in 2024

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))

Recent news on IDEXX Laboratories

See all news